Neurocrine Biosciences (NBIX) Shares Issued: 2010-2021
Historic Shares Issued for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2021 value amounting to $1.8 million.
- Neurocrine Biosciences' Shares Issued fell 5.26% to $1.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $27.5 million, marking a year-over-year decrease of 5.50%. This contributed to the annual value of $122.1 million for FY2024, which is 86.98% up from last year.
- Latest data reveals that Neurocrine Biosciences reported Shares Issued of $1.8 million as of Q4 2021, which was down 76.00% from $7.5 million recorded in Q3 2021.
- Neurocrine Biosciences' Shares Issued's 5-year high stood at $16.1 million during Q1 2018, with a 5-year trough of $1.5 million in Q1 2017.
- In the last 3 years, Neurocrine Biosciences' Shares Issued had a median value of $5.7 million in 2020 and averaged $7.4 million.
- Its Shares Issued has fluctuated over the past 5 years, first soared by 8,788.89% in 2017, then tumbled by 84.68% in 2020.
- Over the past 5 years, Neurocrine Biosciences' Shares Issued (Quarterly) stood at $5.6 million in 2017, then plummeted by 68.71% to $1.8 million in 2018, then soared by 607.76% to $12.4 million in 2019, then slumped by 84.68% to $1.9 million in 2020, then fell by 5.26% to $1.8 million in 2021.
- Its Shares Issued was $1.8 million in Q4 2021, compared to $7.5 million in Q3 2021 and $3.0 million in Q2 2021.